ClinicalTrials.gov 临床试验·· 29 天前AI 评分18
Molnupiravir(MK-4482)预防高风险人群COVID-19重症的临床研究(MK-4482-023)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
AI 导读
一项临床研究正在评估Molnupiravir(MK-4482)能否在高风险人群中预防COVID-19重症,对照为安慰剂。该药旨在阻止新冠病毒在体内复制,研究针对因药物不可及或存在药物相互作用而难以使用现有治疗的高风险人群。
来源:ClinicalTrials.gov 临床试验 · clinicaltrials.gov